Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Histone H2A type 1-D (H2AC7) is a core nuclear protein encoded by the HIST1H2AD gene in humans and found in other eukaryotes. It is part of the nucleosome octamer, which packages and organizes DNA into chromatin. Each nucleosome consists of an octamer formed by pairs of the core histones H2A, H2B, H3, and H4, and 146 base pairs of DNA wound around it. H2A type 1-D is a canonical replication-dependent histone, highly conserved and essential for the structural integrity and compaction of DNA, as well as for regulating gene expression, DNA replication, and epigenetic modifications. Transcripts of this gene typically lack introns and polyA tails, and are part of the large histone gene cluster on human chromosome 6. While histone function and modification are tightly linked to normal cell function, genome stability, and disease processes such as cancer, histone H2A type 1-D itself is not a direct therapeutic target or biomarker.
No drugs directly targeting this molecule; modifications of histones can be targeted indirectly by drugs such as HDAC inhibitors, but not specific to H2A type 1-D
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Histone H2A type 1-D (H2AC7).